147 related articles for article (PubMed ID: 11907714)
1. The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model.
Vandenput L; Swinnen JV; Van Herck E; Verstuyf A; Boonen S; Bouillon R; Vanderschueren D
Calcif Tissue Int; 2002 Mar; 70(3):170-5. PubMed ID: 11907714
[TBL] [Abstract][Full Text] [Related]
2. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
[TBL] [Abstract][Full Text] [Related]
3. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency.
Vanderschueren D; Van Herck E; Suiker AM; Visser WJ; Schot LP; Bouillon R
Endocrinology; 1992 May; 130(5):2906-16. PubMed ID: 1572302
[TBL] [Abstract][Full Text] [Related]
4. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
Seidlová-Wuttke D; Jarry H; Pitzel L; Wuttke W
Maturitas; 2005 Jun; 51(2):177-86. PubMed ID: 15917159
[TBL] [Abstract][Full Text] [Related]
5. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats.
Vanderschueren D; van Herck E; Nijs J; Ederveen AG; De Coster R; Bouillon R
Endocrinology; 1997 Jun; 138(6):2301-7. PubMed ID: 9165015
[TBL] [Abstract][Full Text] [Related]
7. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
[TBL] [Abstract][Full Text] [Related]
8. Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model.
Vandenput L; Swinnen JV; Boonen S; Van Herck E; Erben RG; Bouillon R; Vanderschueren D
J Bone Miner Res; 2004 Sep; 19(9):1462-70. PubMed ID: 15312246
[TBL] [Abstract][Full Text] [Related]
9. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
11. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
[TBL] [Abstract][Full Text] [Related]
12. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
Damien E; Price JS; Lanyon LE
J Bone Miner Res; 2000 Nov; 15(11):2169-77. PubMed ID: 11092397
[TBL] [Abstract][Full Text] [Related]
13. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement.
Vanderschueren D; Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R
Endocrinology; 2000 May; 141(5):1642-7. PubMed ID: 10803572
[TBL] [Abstract][Full Text] [Related]
14. Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
Sibonga JD; Dobnig H; Harden RM; Turner RT
Endocrinology; 1998 Sep; 139(9):3736-42. PubMed ID: 9724025
[TBL] [Abstract][Full Text] [Related]
15. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
[TBL] [Abstract][Full Text] [Related]
16. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model.
Vanderschueren D; Boonen S; Ederveen AG; de Coster R; Van Herck E; Moermans K; Vandenput L; Verstuyf A; Bouillon R
Bone; 2000 Nov; 27(5):611-7. PubMed ID: 11062346
[TBL] [Abstract][Full Text] [Related]
17. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
Bauss F; Lang K; Dony C; Kling L
Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
[TBL] [Abstract][Full Text] [Related]
18. Bone and mineral metabolism in the adult guinea pig: long-term effects of estrogen and androgen deficiency.
Vanderschueren D; Van Herck E; Suiker AM; Allewaert K; Visser WJ; Geusens P; Bouillon R
J Bone Miner Res; 1992 Dec; 7(12):1407-15. PubMed ID: 1481727
[TBL] [Abstract][Full Text] [Related]
19. Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model.
Venken K; Boonen S; Van Herck E; Vandenput L; Kumar N; Sitruk-Ware R; Sundaram K; Bouillon R; Vanderschueren D
Bone; 2005 Apr; 36(4):663-70. PubMed ID: 15784189
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes in rat prostate after activation or blocking of the androgen and estrogen receptor.
Nellemann C; Dalgaard M; Holst B; Bonefeld-Jørgensen EC; Vinggaard AM
Mol Cell Endocrinol; 2005 Jun; 237(1-2):25-35. PubMed ID: 15925091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
